Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

668 ARTÍCULOS , VIENDO DEL 166 AL 180

Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy

Jiang Q.

Free Radic Biol Med. 2014 Jul;72:76-90. doi: 10.1016/j.freeradbiomed.2014.03.035. Epub 2014 Apr 3.

Cryptococcal meningitis in a goat--a case report

Stilwell G, Pissarra H.

BMC Vet Res. 2014 Apr 5;10:84. doi: 10.1186/1746-6148-10-84.

Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1

Moghadam KK, Pizza F, Tonon C, Lodi R, Carelli V, Poli F, Franceschini C, Barboni P, Seri M, Ferrari S, La Morgia C, Testa C, Cornelio F, Liguori R, Winkelmann J, Lin L, Mignot E, Plazzi G.

Sleep Med. 2014 May;15(5):582-5. doi: 10.1016/j.sleep.2013.09.028. Epub 2014 Feb 12.

Acute lymphocytic cholangitis and liver failure in an Amur tiger (Panthera tigris altaica)

Crook EK, Carpenter NA.

J Zoo Wildl Med. 2014 Mar;45(1):143-7. doi: 10.1638/2012-0016R2.1.

Antiphospholipid antibodies and cerebellar ataxia: a clinical analysis and literature review

Chen WH, Chen CH, Chui C, Lui CC, Chen CJ, Yin HL.

Neuroimmunomodulation. 2014;21(6):283-90. doi: 10.1159/000354614. Epub 2014 Apr 1.

Clinico-Pathological Correlation in Progressive Ataxia and Palatal Tremor: A Novel Tauopathy

Mari Z, Halls AJM, Vortmeyer A, Zhukareva V, Uryu K, Lee VM, Hallett M.

Mov Disord Clin Pract. 2014 Apr 10;1(1):50-56. doi: 10.1002/mdc3.12014. eCollection 2014 Apr.

Tremor in Spinocerebellar Ataxia Type 12

Kalia LV, Rockman-Greenberg C, Borys A, Lang AE.

Mov Disord Clin Pract. 2014 Apr 10;1(1):76-78. doi: 10.1002/mdc3.12015. eCollection 2014 Apr.

Dystonic Tremor and Spasmodic Dysphonia in Spinocerebellar Ataxia Type 12

Ganos C, Saifee TA, Kassavetis P, Erro R, Batla A, Cordivari C, Bhatia KP.

Mov Disord Clin Pract. 2014 Apr 10;1(1):79-81. doi: 10.1002/mdc3.12006. eCollection 2014 Apr.

FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion

Bäumer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, Ansorge O.

Acta Neuropathol. 2014 Oct;128(4):597-604. doi: 10.1007/s00401-014-1277-z. Epub 2014 Apr 10.

A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

Steinhoff BJ, Hamer H, Trinka E, Schulze-Bonhage A, Bien C, Mayer T, Baumgartner C, Lerche H, Noachtar S.

Epilepsy Res. 2014 Jul;108(5):986-8. doi: 10.1016/j.eplepsyres.2014.03.015. Epub 2014 Mar 27.

A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: functional analysis of the mutant protein

Ersoy Tunalı N, Marobbio CM, Tiryakioğlu NO, Punzi G, Saygılı SK, Onal H, Palmieri F.

Mol Genet Metab. 2014 May;112(1):25-9. doi: 10.1016/j.ymgme.2014.03.002. Epub 2014 Mar 20.

CANOMAD responding to weekly treatment with intravenous immunoglobulin (IVIg)

Krenn M, Keir G, Wieshmann UC.

BMJ Case Rep. 2014 Apr 10;2014:bcr2013202545. doi: 10.1136/bcr-2013-202545.

Reversible cerebellar ataxia due to ovarian teratoma

Park JE, Liang TW.

J Clin Neurosci. 2014 Aug;21(8):1467-9. doi: 10.1016/j.jocn.2013.12.019. Epub 2014 Apr 13.

Cerebellar ataxia and functional genomics: Identifying the routes to cerebellar neurodegeneration

Smeets CJ, Verbeek DS.

Biochim Biophys Acta. 2014 Oct;1842(10):2030-2038. doi: 10.1016/j.bbadis.2014.04.004. Epub 2014 Apr 13.

Late-onset nonketotic hyperglycinemia with a heterozygous novel point mutation of the GLDC gene

Brenton JN, Rust RS.

Pediatr Neurol. 2014 May;50(5):536-8. doi: 10.1016/j.pediatrneurol.2014.01.018. Epub 2014 Jan 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias